Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Guaranteed Rate Affinity Celebrates National Operations Day, Honoring EVP Jaime Joyce and the Team Behind Its Seamless Loan Process
-
Advanced Fences: Elevating Security and Style with the Launch of Custom Driveway Gates and Iron Fencing
-
Skycorp Solar Group Limited Appoints Feng Shibo to Board of Directors
-
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
-
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Janover Purchases Approximately $5.0 Million of Solana (SOL) as Part of New Treasury Strategy
-
Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025
-
Mixed Martial Arts Group Limited Secures $2 Million Non-Dilutive Financing
-
GlobalTech Corporation Acquires Exclusive Worldwide License to CricksLab Core Engine Software for Development for Use in Bat-and-Ball Sports
-
Blue Star Families Launches New Chapter in North Carolina to Serve More than 240,000 Local Military Families
-
ImPact Biotech Announces New Data Presentations at AUA 2025 Highlighting Safety and Efficacy of Padeliporfin VTP
-
Sprott Physical Gold Trust Updates Its “At-The-Market” Equity Program
-
Kenges Rakishev Highlights Kazakhstan’s Potential as Global Gas Hub in Astana Gas and Petrochemicals Forum
-
MEXC Among Top 3 CEXs with $1.79B Monthly Inflows, Driven by Innovative Strategies
-
Hofseth Biocare ASA: HBC ANNUAL REPORT 2024
-
Form 8.3 - Assura PLC
-
IDEX Biometrics ASA: Extraordinary general meeting held on 11 April 2025
-
Results of the Annual General Meeting of ISS A/S
-
MILLER PROJECT: CANADA CARBON CONCERNED ABOUT CPTAQ DECISION ON THE DEVELOPMENT OF CRITICAL AND STRATEGIC MINERALS IN QUEBEC
-
Mandalay Resources Reports Q1 2025 Gold and Antimony Production In-Line with 2025 Guidance
-
Palvella Therapeutics Announces QTORIN™ Rapamycin 3.9% Anhydrous Gel for the Treatment of Microcystic Lymphatic Malformations Featured in Oral Presentation by Amy Paller, M.S., M.D., Chair of Dermat
-
Don’t just read the stats, change the future for seniors with your vote
-
Auction result of Treasury Bonds - RIKB 26 1015 - RIKB 35 0917
-
Reporting on transactions in Danish Aerospace Company A/S’ shares by persons discharging managerial responsibilities and persons closely associated with them
-
ThriveCart Launches Custom-Built Stripe Connect+ and Innovative Pro+ Platform Features
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Invesco Ltd: Form 8.3 - Qualcomm Incorporated; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Lithium Argentina and Ganfeng Advance Plan to Jointly Develop the Pozuelos-Pastos Grandes Basins
-
Innventure Reports Fourth Quarter and Full Year 2024 Results
-
BexBack Launches Double Deposit Bonus, $50 Welcome Bonus and 100x Leverage Crypto Trading No KYC
-
Northland Power Announces its First Quarter 2025 Financial Results Release Date and Provides Investor Call and Webcast Details
-
ExGen Announces ROFR and Convertible Loan to Private Company in Connection with the Spark South Lithium Project in Elko County Nevada
-
Integer Holdings Corporation Issues Statement on Tariffs
-
American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025
-
Aya Gold & Silver Announces Record Q1-2025 Production Results
-
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
-
BON Announces Apple Polyphenol Commercial Order Signed
-
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
-
Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 Monotherapy at 1.5 mCi in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
-
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025
-
ECARX Powers Launch of Geely Galaxy Xingyao 8, Delivering Cutting-Edge Intelligent Cockpit and Driving Experience
-
Regarding the decision of the Lithuanian Court of Appeal in the insurance compensation case
-
Fluxys Belgium - Regulated information: Ordinary and Extraordinary General Meetings on 13th May 2025
-
Optima Health to acquire Cognate Health Limited
-
Barrick to Report First Quarter 2025 Results on May 7, 2025
-
Notice of Annual General Meeting 2025
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Greencore Group plc
-
Ring Energy Provides Board of Directors Update
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Bakkavor Group plc


